The motif D loop of human immunodeficiency virus type 1 reverse transcriptase is critical for nucleoside 5′-triphosphate selectivity

被引:17
|
作者
Canard, B
Chowdhury, K
Sarfati, R
Doublié, S
Richardson, CC [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[2] Ecole Super Ingn Luminy, CNRS, F-13288 Marseille 9, France
[3] Inst Pasteur, F-75724 Paris 15, France
关键词
D O I
10.1074/jbc.274.50.35768
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human immunodeficiency virus type 1 reverse transcriptase (RT) has limited homology with DNA and RNA polymerases. The conserved Lys-220 of motif D is a signature of RNA-dependent polymerases. Motif D is located in the "palm" domain and forms a small loop from Thr-215 to Lys-223. This loop is absent from the polymerase I family of DNA-dependent polymerases. Analysis of RT structures in comparison with other polymerases reveals that the motif D loop has the potential to undergo a conformational change upon binding a nucleotide. We find that amino acid changes in motif D affect the interaction of RT with the incoming nucleotide. A chimeric RT in which the loop of motif D is substituted by the corresponding amino acid segment from Tag DNA polymerase lacking this loop has a decreased affinity for incoming nucleotides. We have also constructed a mutant RT where the conserved lysine at position 220 within the motif D is substituted with glutamine. Both RT(K220Q) and the chimeric RT are resistant in vitro to 3'-deoxy S'-azidothymidine 5'-triphosphate (AZTTP). These results suggest that motif D is interacting with the incoming nucleotide and a determinant of the sensitivity of reverse transcriptases to AZTTP. We do not observe any interaction of motif D with the template primer.
引用
收藏
页码:35768 / 35776
页数:9
相关论文
共 50 条
  • [1] Nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase
    Sharma, PL
    Nurpeisov, V
    Hernandez-Santiago, B
    Beltran, T
    Schinazi, RF
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (09) : 895 - 919
  • [2] Human immunodeficiency virus type-1 reverse transcriptase - Contribution of Met-184 to binding of nucleoside 5'-triphosphate
    Wilson, JE
    Aulabaugh, A
    Caligan, B
    McPherson, S
    Wakefield, JK
    Jablonski, S
    Morrow, CD
    Reardon, JE
    Furman, PA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (23) : 13656 - 13662
  • [3] ATP-dependent removal of nucleoside reverse transcriptase inhibitors by human immunodeficiency virus type 1 reverse transcriptase
    Naeger, LK
    Margot, NA
    Miller, MD
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (07) : 2179 - 2184
  • [4] Human immunodeficiency virus type 1 reverse transcriptase
    Hottiger, M
    Hubscher, U
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1996, 377 (02): : 97 - 120
  • [5] A Bifunctional Nucleoside Probe for the Inhibition of the Human Immunodeficiency Virus-Type 1 Reverse Transcriptase
    Shaw, Tyler A.
    Ablenas, Christopher J.
    Desrochers, Genevieve F.
    Powdrill, Megan H.
    Bilodeau, Didier A.
    Vincent-Rocan, Jean-Francois
    Niu, Meijuan
    Monette, Anne
    Mouland, Andrew J.
    Beauchemin, Andre M.
    Pezacki, John Paul
    BIOCONJUGATE CHEMISTRY, 2020, 31 (05) : 1537 - 1544
  • [6] Non nucleoside inhibitors of reverse transcriptase of human immunodeficiency virus
    Roca, B
    Simón, E
    MEDICINA CLINICA, 1998, 111 (17): : 660 - 662
  • [7] Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1
    Balzarini, J
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (09) : 921 - 944
  • [8] The incorporation of nucleoside analogs by human immunodeficiency virus type 1 reverse transcriptase decreases in the presence of polyamines
    Bakhanashvili, Mary
    Rahav, Galia
    FEBS LETTERS, 2006, 580 (22): : 5363 - 5370
  • [9] NUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS AND RESISTANCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    JOHNSON, VA
    JOURNAL OF INFECTIOUS DISEASES, 1995, 171 : S140 - S149
  • [10] Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors
    Auwerx, J
    Esnouf, R
    De Clercq, E
    Balzarini, J
    MOLECULAR PHARMACOLOGY, 2004, 65 (01) : 244 - 251